Ellen Pure

16PUBLICATIONS

108CO-AUTHORS

Tissue engineeringPredictive and prognostic markersMolecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 27, 2026

Bispecific antibody engineered extracellular vesicles redirect T cells to prevent postoperative epidural fibrosis.

|Feb 13, 2026

Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.

Khuloud Bajbouj, Zebin Xiao, Leslie Todd

|Oct 17, 2025

A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors.

Haijiao Liu, Estela Noguera-Ortega, Xuanqi Dong

|Sep 09, 2025

Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer.

Taslim A Al-Hilal, Maria-Anna Chrysovergi, Paula E Grasberger

|Mar 18, 2025

The fibroinflammatory response in cancer.

Zebin Xiao, Ellen Puré

|Aug 21, 2024

Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies.

Zhen Lu, Ioannis Verginadis, Motofumi Kumazoe

Pageof 3

Frequent Collaborators

Zebin Xiao

Carl H June

Wei Guo

Leslie Todd

Estela Noguera-Ortega

Steven M Albelda

Haig Aghajanian

Drew Weissman

Serge Y Fuchs

Tyler E Papp

Frequent Collaborators

Zebin Xiao

Carl H June

Wei Guo

Leslie Todd